Peery Kimberly R. 4

What Happened
Kimberly R. Peery, Chief Financial Officer of Stereotaxis, was granted a 40,000-share derivative award (reported as a grant/award) on April 11, 2026. The filing reports an acquisition amount of 40,000 shares at $0.00, indicating a vested equity award (options) rather than an open-market purchase or sale. There was no cash paid at grant according to the report.

Key Details

• Transaction date: 2026-04-11; filing date: 2026-04-13 (appears timely, within the usual 2-business-day reporting window).
• Amount: 40,000 shares (derivative award) at $0.00; total reported value $0 at grant.
• Shares owned after transaction: not specified in the excerpted transaction data.
• Footnote: Options vest 25% one year after grant, then the remaining 75% vests ratably per month over the next three years.
• No indication in this filing of exercise, sale, tax withholding, or a 10b5-1 plan.

Context
This was an equity award (derivative/option grant) to an executive — not an immediate sale or open-market purchase. Such grants are common for executive compensation and vest over time; they do not reflect an immediate cash transaction or share sale. Retail investors often watch grants for dilution and incentive alignment, but grants alone don’t indicate buying or selling sentiment.